Picture of Vertex Pharmaceuticals logo

VRTX Vertex Pharmaceuticals Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Vertex Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments2,0893,1683,8086,6597,525
Net Total Accounts Receivable
Net Total Receivables3104156348851,137
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets2,6493,8434,8238,1339,561
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment7898128331,2841,424
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets3,5466,2468,31811,75213,433
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities8071,1201,3351,8782,142
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities1,5171,8112,2333,0653,333
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity2,0294,4356,0858,68710,100
Total Liabilities & Shareholders' Equity3,5466,2468,31811,75213,433
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email